Compare · GH secretagogue
CJC-1295 vs Tesamorelin
Both are gh secretagogue compounds. Here's how they line up on the evidence — graded the same way.
| CJC-1295 | Tesamorelin | |
|---|---|---|
| Evidence | 6/10 | 8/10 |
| Class | GH secretagogue | GH secretagogue |
| Summary | A long-acting GHRH analog that raises GH and IGF-1 in short human trials, but has no clinical-outcome data, is not FDA-approved, and is banned in sport. | Tesamorelin is an FDA-approved GHRH analogue with solid RCT evidence for shrinking visceral fat in HIV-associated lipodystrophy, but little proof outside that group. |
| Full profile → | Full profile → |
CJC-1295
CJC-1295 is a lab-made copy of a natural hormone called GHRH (growth hormone-releasing hormone — the signal that tells your body to make growth hormone). It's built to nudge your body into releasing more of its own growth hormone (GH). Short studies in people confirm it does raise GH and IGF-1 (a…
Tesamorelin
Tesamorelin, sold as Egrifta, is one of the few peptides in this space that actually has strong, FDA-grade human evidence behind it. The catch: almost all of that evidence comes from one specific group of patients. And a lot of the way the compound gets marketed elsewhere goes well past what those…